Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1/2 randomized, controlled clinical trial of AB-PA01 in patients patients with P. aeruginosa bacteremia

Next Previous
Trial Profile

A Phase 1/2 randomized, controlled clinical trial of AB-PA01 in patients patients with P. aeruginosa bacteremia

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 28 Sep 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AP PA01 (Primary)
  • Indications Pseudomonal infections
  • Focus Adverse reactions; Therapeutic Use

Most Recent Events

  • 28 Sep 2018 New trial record
  • 18 Sep 2018 According to an AmpliPhi Biosciences Corporation media release, FDA is in general agreement with the design of proposed this clinical trial and no additional preclinical or clinical data are required to proceed with both trials.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top